Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Journal of Long-Term Effects of Medical Implants
SJR: 0.145 SNIP: 0.491 CiteScore™: 0.89

ISSN Печать: 1050-6934
ISSN Онлайн: 1940-4379

Выпуски:
Том 30, 2020 Том 29, 2019 Том 28, 2018 Том 27, 2017 Том 26, 2016 Том 25, 2015 Том 24, 2014 Том 23, 2013 Том 22, 2012 Том 21, 2011 Том 20, 2010 Том 19, 2009 Том 18, 2008 Том 17, 2007 Том 16, 2006 Том 15, 2005 Том 14, 2004 Том 13, 2003 Том 12, 2002 Том 11, 2001 Том 10, 2000

Journal of Long-Term Effects of Medical Implants

DOI: 10.1615/JLongTermEffMedImplants.v18.i1.310
33 pages

Abstract of "Ethical Issues in Male Contraceptive Implant Studies"

Sujoy K. Guha
School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, 721 302 India

Краткое описание

Single-intervention, long-acting, and reversible contraceptive for the male is an important need in health care and for societal well-being. A bioactive, sperm-inactivating polymeric drug implant instilled by an injection into the lumen of the male reproductive duct, the vas deferens, offers scope for realization of an optimal contraceptive. In clinical trials, subjects are healthy and not diseased. Also, the implant does not prevent a disease. Moreover, a normal physiological function is the target for suppression, which sets contraceptive implants apart from the general class of drugs that are administered to correct a pathology. Therefore, the ethical justification underlying development trials and dissemination of the technology lies in the psychological gains arising from the usage. Psychological gains are difficult to quantify and in consequence ethical grounds become abstract. A direct fallout is that the standards in the implant development and trials need to be very high and side effects and adverse effects have to be minimal. Complications that are a routine part of normal life are not acceptable in the context of contraceptives. Normal semen has abnormal sperms and there is a small but finite probability of a pregnancy with genetic abnormalities in the fetus. But with a vas implant, any pregnancy with genetic abnormality is not acceptable. Hence, ethics demands very strict genotoxic safety with the implant, even more so than as pertains to normal reproduction. Trial failure is a pregnancy and brings in the desire and consent for termination of pregnancy. At induction, a subject opting for pregnancy termination and later, on contraception failure, wants pregnancy continuation, generates an ethical dilemma, which is under debate. The theoretical risk of genetic abnormality being ever present, it seems that ethics would suggest that the subject be strongly advised to undergo pregnancy termination.


Articles with similar content:

Sham Surgeries: Have We Gone Too Far?
Ethics in Biology, Engineering and Medicine: An International Journal, Vol.1, 2010, issue 2
Mohit Bhandari, Victor K. Wu
Heterotopic Ossification: A Review of Etiology, Diagnosis, and Clinical Management
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.27, 2015, issue 2-4
Donald Hamby, Scott Strum, Justice Otchere
Exercise Therapy After Spinal Cord Injury: The Effects on Heath and Function
Critical Reviews™ in Biomedical Engineering, Vol.37, 2009, issue 1-2
David S. Ditor, Audrey L. Hicks
The significance of Fear as an "Equal Opportunity Component" in the Articulation & Acceptance of Informed Consent in Dentistry
Ethics in Biology, Engineering and Medicine: An International Journal, Vol.3, 2012, issue 1-3
Boyd W. Shepherd
Ethical Issues in a Case Control Study of Maternal Periodontal Health Status and Low Birth Weight Babies in North India
Ethics in Biology, Engineering and Medicine: An International Journal, Vol.3, 2012, issue 1-3
Sujata, Rameshwari Singhal, Shally Avasthi, Pavitra Rastogi